A55. EXERCISE RELATED STUDIES AND CLINICAL STUDIES IN PULMONARY VASCULAR DISEASES最新文献

筛选
英文 中文
Pulmonary Arterial Hypertension with Below Threshold Pulmonary Vascular Resistance 肺血管阻力低于阈值的肺动脉高压
A55. EXERCISE RELATED STUDIES AND CLINICAL STUDIES IN PULMONARY VASCULAR DISEASES Pub Date : 2020-05-01 DOI: 10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a2048
E. Lau, S. Ratwatte, J. Anderson, C. Corrigan, J. Feenstra, D. Keating, H.M. Whitford, M. Lavender, J. Wrobel, T. Williams, E. Kotlyar, A. Keogh, G. Strange, PHSANZ Registry
{"title":"Pulmonary Arterial Hypertension with Below Threshold Pulmonary Vascular Resistance","authors":"E. Lau, S. Ratwatte, J. Anderson, C. Corrigan, J. Feenstra, D. Keating, H.M. Whitford, M. Lavender, J. Wrobel, T. Williams, E. Kotlyar, A. Keogh, G. Strange, PHSANZ Registry","doi":"10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a2048","DOIUrl":"https://doi.org/10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a2048","url":null,"abstract":"","PeriodicalId":177606,"journal":{"name":"A55. EXERCISE RELATED STUDIES AND CLINICAL STUDIES IN PULMONARY VASCULAR DISEASES","volume":"24 15","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141207559","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exercise Capacity in Patients with Pulmonary Arterial Hypertension: Multicentric Analysis of Aerobic Capacity and Survival 肺动脉高压患者的运动能力:有氧能力和生存的多中心分析
A55. EXERCISE RELATED STUDIES AND CLINICAL STUDIES IN PULMONARY VASCULAR DISEASES Pub Date : 2020-05-01 DOI: 10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a2066
I. Blanco, R. Torres-Castro, E. Gimeno-Santos, J. Moisés, M. L. Coronel, L. Sebastián, P. Escribano-Subías, J. Barberà
{"title":"Exercise Capacity in Patients with Pulmonary Arterial Hypertension: Multicentric Analysis of Aerobic Capacity and Survival","authors":"I. Blanco, R. Torres-Castro, E. Gimeno-Santos, J. Moisés, M. L. Coronel, L. Sebastián, P. Escribano-Subías, J. Barberà","doi":"10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a2066","DOIUrl":"https://doi.org/10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a2066","url":null,"abstract":"","PeriodicalId":177606,"journal":{"name":"A55. EXERCISE RELATED STUDIES AND CLINICAL STUDIES IN PULMONARY VASCULAR DISEASES","volume":"2 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"128877931","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prognostic Value of Stroke Volume Index in Patients with Pulmonary Arterial Hypertension at Intermediate Risk 中危肺动脉高压患者脑卒中容量指数的预后价值
A55. EXERCISE RELATED STUDIES AND CLINICAL STUDIES IN PULMONARY VASCULAR DISEASES Pub Date : 2019-10-01 DOI: 10.1093/eurheartj/ehz745.1062
F. Dardi, E. Gotti, M. Palazzini, A. Rinaldi, E. Zuffa, F. Pasca, A. D. Lorenzis, D. Guarino, I. Magnani, M. Rotunno, A. Manes, N. Galiè
{"title":"Prognostic Value of Stroke Volume Index in Patients with Pulmonary Arterial Hypertension at Intermediate Risk","authors":"F. Dardi, E. Gotti, M. Palazzini, A. Rinaldi, E. Zuffa, F. Pasca, A. D. Lorenzis, D. Guarino, I. Magnani, M. Rotunno, A. Manes, N. Galiè","doi":"10.1093/eurheartj/ehz745.1062","DOIUrl":"https://doi.org/10.1093/eurheartj/ehz745.1062","url":null,"abstract":"\u0000 \u0000 \u0000 Current pulmonary hypertension (PH) guidelines stratify the risk of patients with pulmonary arterial hypertension (PAH) using a multiparametric approach. Low, intermediate and high-risk are defined by estimated 1-year mortality of <5%, 5–10% and >10%, respectively. This risk assessment has been recently validated in 3 cohorts of PAH patients and a simplified risk table for patients with idiopathic/heritable (I/H) PAH and PAH associated with connective tissue disease (CTD) and congenital heart disease (CHD) has been recently proposed and validated. However, with this method most of the patients are classified in the intermediate risk category and additional strategies are required to further stratify this group of PAH patients.\u0000 \u0000 \u0000 \u0000 To evaluate the prognostic value of SVI measured with right heart catheterization (RHC) in patients at intermediate-risk.\u0000 \u0000 \u0000 \u0000 All treatment naïve patients with I/H-PAH, CTD-PAH and CHD-PAH referred to a single centre were included from 2003 to 2017. All patients were assessed at baseline and at the 1st follow-up at 3–4 months after starting PAH-specific therapy (1st F-UP) with RHC, brain natriuretic peptide (BNP) plasma levels, 6-min walking distance (6MWD) and WHO functional class. We applied a simplified risk assessment strategy using the following criteria: WHO functional class, 6MWD, right atrial pressure or BNP plasma levels and cardiac index (CI) or mixed venous oxygen saturation (SvO2). The last 2 criteria were based on which parameter was available; if both were available the worst was chosen. Risk strata were defined as: Low risk= at least 3 low risk and no high-risk criteria; High risk= at least 2 high risk criteria including CI or SvO2; Intermediate risk= definitions of low or high risk not fulfilled. The prognostic value of SVI was assessed using Cox regression analysis. Intermediate risk patients were further stratified in intermediate-low and intermediate-high risk taking into account the value of SVI that best discriminate prognosis (according to ROC curve analysis). Kaplan Meier curves and Log-rank test were used for survival analysis.\u0000 \u0000 \u0000 \u0000 Seven hundreds and twenty-five patients were enrolled. SVI is able to stratify the prognosis of PAH patients at 1st F-UP [HR 0.979 (0.964–0.994), p-value= 0.008] but not at baseline [HR 0.986 (0.970–1.002), p-value= 0.085]. The best predictive cut-off value is 38 ml/m2 (AUC= 0.66, sensitivity= 73%, specificity= 59%). Survival curves are shown in the Figure.\u0000 Figure 1\u0000 \u0000 \u0000 \u0000 SVI assessed at 1st F-UP is predictive of prognosis and the cut off value of 38 ml/m2 is able to further stratify the survival of intermediate risk PAH patients.\u0000 \u0000 \u0000 \u0000 None\u0000","PeriodicalId":177606,"journal":{"name":"A55. EXERCISE RELATED STUDIES AND CLINICAL STUDIES IN PULMONARY VASCULAR DISEASES","volume":"2 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"129691225","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书